Published • loading... • Updated
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
Summary by dailyguardian.ca
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Apeloa Honored with Frost & Sullivan's 2026 Global CDMO Company of the Year Award
Global GIL Recognition Spotlights Apeloa’s End-to-End “API + Drug Product” Integration, Advanced Technology Platforms, and Its Compliance Track Record in Regulated Markets SHANGHAI, Sept. 17, 2026 (GLOBE NEWSWIRE) — Apeloa Pharmaceutical Co., Ltd. (Apeloa; SZSE: 000739.SZ), a leading contract development and manufacturing organization (CDMO) and technology-driven pharmaceutical manufacturer, announced that it has been awarded the “2026 [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
